Site Navigation
 

Lymphoma Information Network - Hodgkin's Disease and the Non-Hodgkin's Lymphomas
Title Page

Site Map

Your Host

Adult Non-Hodgkin's Lymphoma: Chemotherapy

  Chemotherapy Info:

Adult Lymphoma
Hodgkin's
NHL
DiagnosisTreatmentChemotherapyImmunotherapyTransplantsResources

ChildhoodChildhood NHL
Childhood HD

 

 

 

 

 

 

 

 

 

 

Chemotherapy is the use of drugs to kill cancer cells and shrink tumors. Chemotherapy may be taken by pill, or it may be put into the body by inserting a needle into a vein or muscle.

Chemotherapy is called a systemic treatment because the drugs enter the bloodstream, travel through the body, and can kill cancer cells throughout the body.


Combination Chemotherapy is the use of a number of drugs together to combat the cancer.   They often have acronyms for names like CHOP, CVP and COP.

Chemotherapy is given in measured doses.  Often a chemotherapy regimen will be given in cycles - treatments spaced over 

a period of days.  The number of cycles vary according to the chemotherapy regime and the extent of the disease.

Chemotherapy is delivered many different ways depending on the drugs and treatment. Intravenous means delivered by inserting a needle in a vein, orally is by mouth, and via catheter or port is by a tube inserted into the chest via a surgical procedure.  As always consult with your own doctors on the best treatment for you given your specific disease and its presentation.

A newer treatment uses immunotherapyThe body's own immune system is used to fight the cancer.  One group of agents currently used are monoclonal antibodies - antibodies which seek out cancer cells and either have the body identify them for destruction or kill them using an attached radioactive isotope. This may offer new hope for many low grade and follicular NHL patients. One type of antibody, Rituxan (rituximab/MabThera), has recently received US FDA approval as have Bexxar and Zevalin

Chemotherapy is tough on the body.  There are a number of side effects which can include nausea and hair loss.  Nausea is controllable with newer drugs such as Zofran and Kytril.  Hair loss is another matter - many people come up with creative coping mechanisms including scarves and hats.  Wigs are also an option and should be explored before chemotherapy is desired.

For Non-Hodgkin's lymphoma that is resistant to chemotherapy, bone marrow or stem cell transplantation is an option.  More information is found on the Lymphoma Transplant Resource Page.

Clinical trials are often used for people who are not responsive to conventional treatment or who wish to help researchers test new therapies.

A list of questions you can use to discuss chemotherapy treatment options and what to look for in after treatment warning signs.

For specific types of treatment see the National Cancer Institute (NCI) data sheets listed under the Non-Hodgkin's Lymphoma: Resources Page.


Further Reading / In-Depth

Non-Hodgkin's Lymphomas, Peter M. Mauch (Editor), James O. Armitage (Editor), et al., 2004.

  • Section III: Treatment Principles and Techniques
    • Chapter 12: Principles of Chemotherapy and Combined Modality Therapy
Living With Lymphoma, Elizabeth Adler, Oct. 2005
  • Chapter 3: Chemotherapy

General Support

Catheters

Drug Information

Immunotherapy / Monoclonal Antibodies

Side Effects

Blood Work

Nutrition

  • Nutrition in Cancer Care  New URL
  • Lymphoma patients should avoid the supplement Melatonin - the Melatonin FAQ concurs with this.  New URL

Clinical Trials


For more information on Adult Non-Hodgkin's Lymphoma, please see the following pages: :

Other pages you may want to visit:


This page is a work in progress - if you have more complete information, references, or other information please contact the author. The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions.

Copyright © 1998-2005 Lymphoma Information Network - All Rights Reserved
http://www.LymphomaInfo.net/
Updated November 18, 2005